These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 10444217

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Nasal hyperreactivity. Allergic rhinitis and its differential diagnoses. Consensus report of pathophysiology, classification, diagnosis and therapy].
    HNO; 1997 Apr; 45(4):189-201. PubMed ID: 9221257
    [No Abstract] [Full Text] [Related]

  • 23. Induction of nasal hyper-responsiveness by allergen challenge in allergic rhinitis: the role of afferent and efferent nerves.
    Sheahan P, Walsh RM, Walsh MA, Costello RW.
    Clin Exp Allergy; 2005 Jan; 35(1):45-51. PubMed ID: 15649265
    [Abstract] [Full Text] [Related]

  • 24. Allergic rhinitis.
    Kemp AS.
    Paediatr Respir Rev; 2009 Jun; 10(2):63-8. PubMed ID: 19410204
    [Abstract] [Full Text] [Related]

  • 25. A multicenter trial of specific local nasal immunotherapy.
    Motta G, Passali D, De Vincentiis I, Ottaviani A, Maurizi M, Sartoris A, Pallestrini E, Motta S, Salzano FA.
    Laryngoscope; 2000 Jan; 110(1):132-9. PubMed ID: 10646729
    [Abstract] [Full Text] [Related]

  • 26. Allergic diseases of the upper respiratory tract.
    Taylor G.
    Clin Allergy; 1973 Dec; 3 Suppl():639-51. PubMed ID: 4536395
    [No Abstract] [Full Text] [Related]

  • 27. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J, Feliú A, Subiza JL, Uhlig J, Fernández-Caldas E.
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy].
    Modrzyński M, Mazurek H, Zawisza E.
    Przegl Lek; 2005 Jun; 62(12):1337-42. PubMed ID: 16786743
    [Abstract] [Full Text] [Related]

  • 30. Vascular endothelial growth factor in allergen-induced nasal inflammation.
    Choi GS, Park HJ, Hur GY, Choi SJ, Shin SY, Ye YM, Park HS.
    Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
    Lee DK, Gray RD, Robb FM, Fujihara S, Lipworth BJ.
    Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. An evaluation of peripheral blood eosinophil/basophil progenitors following nasal allergen challenge in patients with allergic rhinitis.
    Wilson AM, Duong M, Crawford L, Denburg J.
    Clin Exp Allergy; 2005 Jan; 35(1):39-44. PubMed ID: 15649264
    [Abstract] [Full Text] [Related]

  • 37. [How to manage allergic rhinitis in current practice].
    Eloit C, Marmouz F.
    Allerg Immunol (Paris); 2001 Dec; 33(10):406-8. PubMed ID: 11802483
    [Abstract] [Full Text] [Related]

  • 38. [Childhood allergic rhinitis].
    Marmouz F.
    Allerg Immunol (Paris); 2000 Dec; 32(10):381-7. PubMed ID: 11209470
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J, Peake HL, Santos CM, Lean M, Bardin P, Robson R, Haumann B, Loehrer F, Handel ML.
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.